Home/ Supplements/ Zinc/ GI Advantage

GI Advantage

product on market Capsule 1st Phorm Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 44% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

L-glutamine and zinc are supported by moderate evidence for maintaining intestinal barrier function and mucosal health. Licorice and slippery elm are traditionally used for gastrointestinal soothing, though clinical data for these specific botanical extracts remains limited. Quercetin is researched for its antioxidant properties and potential to modulate inflammatory responses.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for GI Advantage
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
44%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

0.86 mg (8% DV)
Within RDA (0.1× RDA) 263 studies (A:6, B:134)
750 mg
Market median: 420.0mg (227 products)
400 mg
Market median: 420.0mg (127 products) 4 studies (A:0, B:1)
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Slippery Elm bark powder
400 mg
Galactoarabinan
250 mg
Dimethylglycine HCl
125 mg
62.5 mg
Market median: 100.0mg (166 products) 11 studies (A:0, B:1)
Marshmallow Root Extract
25 mg

Other Ingredients

Rice Flour Microcrystalline Cellulose Magnesium Stearate Hypromellose
Claims

Label Claims — Verification

Unverified Structure/Function
Info

Product Information

Formulation Notes

Foundation Series Premium comprehensive gastrointestinal system formula Reduce heartburn Decrease gut inflammation Optimize digestion

Additional Information

Nothing compares

Metadata

Product Details

DSLD Entry Date2021-03-25
Product TypeOther Combinations
FormCapsule
DSLD ID242777
Data Updated2026-04-11
Research

Research Evidence

397
Research Sources
55
Avg Quality
200
Meta Analysis
68
Rct
58
Systematic Review
53
Clinical Trial
9
Cochrane Review
2
Narrative Review
2
Regulatory Source
1
Observational
1
Other
1
Openfda Safety
A Zinc supplementation for improving pregnancy and infant outcome
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
Narrative Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Oral zinc for treating diarrhoea in children
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2021 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2010 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Compression bandages or stockings versus no compression for treating venous leg ulcers
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for mental and motor development in children
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Zinc for the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Zinc →
Compare

Similar Products

View all Zinc products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.